Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Tenth Towers Watson alternatives survey says few funds of hedge funds offer credible capability

Tuesday, August 27, 2013

Beverly Chandler, Opalesque London:

The Towers Watson Global Alternatives Survey, produced in conjunction with the Financial Times and in its tenth year, revealed that pension fund alternative assets allocations are now nearly 20% of all pension fund assets across the globe, increasing by 5% from 15 years ago.

Commenting specifically on key trends in hedge funds, the survey said: "The Fund of Hedge Fund (FoHF) industry continues to adjust to the new normal, with FoHFs increasingly working with investors in some form of customised or bespoke manner. Continuing downward pressure on the FoHF fees has resulted in meaningful reduction of the average manager fee rates, although the total fee burden for institutional investors remains significant".

The survey found that institutional investors continue to be discerning about what they want from the hedge fund part of their portfolios. "Which is" the survey says, "low correlation to traditional markets, greater transparency, appropriate liquidity, alignment and appropriate fees."

The survey found that there was less of a take it or leave it attitude between FoHFs and their investors and an increasingly accommodative approach to investor requirements.

Looking forward, Towers Watson believes that only a small number of FoHFs offer a credible capability so they expect more co......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner